Harmony Biosciences Inc.

HRMY | NASDAQ

Price Alert Chart Builder DCF Calculator

$42.10

$0 (0.00%)

Sep 22, 2026, 2:02 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.44B

Enterprise Value $1.92B

Beta 0.93

Average Volume 798.73K

Shares Outstanding (Diluted) 58.77M

Shares Change YoY 0.59%

Institutional Ownership 96.82%

Exchange NASDAQ

ISIN US4131971040

Price Performance

Price Change 1M 10.4%

Price Change 3M 23.2%

Price Change 6M 52.6%

Price Change YTD 12.6%

Price Change 1Y 29.9%

Price Change 3Y 16.0%

Price Change 5Y 11.8%

1M CAGR (ann.) 9.6%

1Y CAGR (ann.) 29.0%

5Y CAGR (ann.) 3.1%

All-Time CAGR 2.1%

Valuation

PE Ratio 13.67

Forward PE 9.62

PEG Ratio -10.66

Forward PEG 1.58

PS Ratio 2.54

Forward PS 2.10

PB Ratio 2.44

P/FCF Ratio 6.87

P/Adj. FCF Ratio 7.76

P/OCF Ratio 6.86

EV/Sales 2.00

EV/EBIT 7.66

EV/EBITDA 7.11

EV/FCF 5.42

Earnings Yield 7.3%

FCF Yield 14.6%

Adj. FCF Yield 12.9%

Financial Health

Net Cash $513.83M

Total Debt $153.96M

Cash & Short-Term Investments $667.79M

Total Assets $1.37B

Current Ratio 3.48

Quick Ratio 3.45

Debt / Equity Ratio 0.15

Debt / EBITDA 0.57

Debt / FCF 0.43

OCF / Debt 2.31

Interest Coverage 17.11

Altman Z-Score 6.00

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 75.4%

Operating Profit Margin 24.0%

EBITDA Margin 28.8%

Net Profit Margin 18.9%

FCF Margin 37.0%

Adj. FCF Margin 32.7%

SBC / Revenue 4.3%

SBC Impact (per share) -11.5%

Returns

Return on Assets 13.2%

Return on Equity 20.1%

Return on Invested Capital 15.0%

Return on Capital Employed 20.3%

Return on Tangible Assets 14.0%

Historical Growth (CAGR)

Revenue CAGR 3Y 24.4%

Revenue CAGR 5Y 32.5%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -2.0%

EPS CAGR 5Y 60.4%

EPS CAGR 10Y N/A

FCF CAGR 3Y 30.1%

FCF CAGR 5Y 48.4%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 13

EPS Growth Next 3Y 27.3%

Revenue Growth Next 3Y 14.7%

Earnings Date Nov 2, 2026

EPS Estimate (next Q) $1.11

EPS Growth Est (next Q) 27.6%

Revenue Est (next Q) $274.55M

Revenue Growth Est (next Q) 14.7%

Fair Value Estimates

Graham Number $34.59

Graham Upside -17.8%

Lynch Fair Value $77

Lynch Upside 82.9%

Price Target $48.50

Price Target Upside 15.2%

Cash Flow

Operating Cash Flow $355.08M

Free Cash Flow $354.9M

Adj. Free Cash Flow $313.95M

FCF Per Share $6.13

OCF Per Share $6.14

OCF/S Ratio 37.0%

Income Statement

Revenue $959.9M

Gross Profit $723.99M

Operating Income $230.65M

EBITDA $270.43M

Net Income $181.27M

EPS (Diluted) $3.08

Revenue / Employee $3.28M

Profit / Employee $618.67K

Employees 293